Search results for "inflammation"

showing 10 items of 2662 documents

PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism

2020

Peroxisome proliferator-activated receptor-γ coactivator (PGC)-1α is a transcriptional coactivator described as a master regulator of mitochondrial biogenesis and function, including oxidative phosphorylation and reactive oxygen species detoxification. PGC-1α is highly expressed in tissues with high energy demands, and it is clearly associated with the pathogenesis of metabolic syndrome and its principal complications including obesity, type 2 diabetes mellitus, cardiovascular disease, and hepatic steatosis. We herein review the molecular pathways regulated by PGC-1α, which connect oxidative stress and mitochondrial metabolism with inflammatory response and metabolic syndrome. PGC-1α regula…

AgingThioredoxin reductaseReview ArticleOxidative phosphorylationmedicine.disease_causeBiochemistryAntioxidantsCoactivatormedicineAnimalsHumansInflammationMetabolic Syndromechemistry.chemical_classificationReactive oxygen speciesOrganelle BiogenesisQH573-671ChemistryCell BiologyGeneral MedicinePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaMitochondriaCell biologyOxidative StressMitochondrial biogenesisOrgan SpecificityThioredoxinCytologyPeroxiredoxinOxidative stressOxidative Medicine and Cellular Longevity
researchProduct

Alzheimer’s disease and infections, where we stand and where we go

2014

Editorial Alzheimer’s disease (AD) is a progressive neurological disorder, which represents the most common form of dementia, one of the major causes of disability in later life. Age is the greatest risk factor for AD, which typically affects people aged 65 years and over, with an age-standardised prevalence of 4.4 [1]. However, AD is not a normal part of ageing and advanced age alone does not justify the disease. Several pathways have been implicated in AD pathophysiology, the most described is the neurodegenerative one, which lead to the brain accumulation of beta-amyloid and neurofibrillary tangles, aggregations of hyperphosphorylated tau protein, macroscopically resulting in brain atrop…

AgingTraumatic brain injuryImmunologyTau proteinperiodontal diseaseDiseaseInfectionsBioinformaticsAtrophyAlzheimer'MedicineDementiaRisk factorAlzheimer's; infections; herpes viruses; periodontal disease; infectionInflammationSettore MED/04 - Patologia Generalebiologybusiness.industryVascular diseaseHerpes virusesOdds ratiomedicine.diseaseinfectionAgeingEditorialImmunologybiology.proteinherpes viruseSettore MED/26 - NeurologiabusinessAlzheimer’s diseaseImmunity & Ageing
researchProduct

Diagnosis and management of asthma in the elderly.

2013

Bronchial asthma is one of the most common chronic diseases worldwide, and by definition not expected to recover with aging. However, the concept that asthma can affect older individuals has been largely denied in the past. In clinical practice, asthma that occurs in the most advanced ages is often diagnosed as COPD, thus leading to undertreatment or improper treatment. The heterogeneity of clinical and functional presentation of geriatric asthma, including the partial loss of reversibility and of the allergic component, contributes to this misconception. A large body of evidence has accumulated demonstrating that the prevalence of asthma in the most advanced ages is similar to that in youn…

Agingmedicine.medical_specialtyComorbiditySettore MED/10 - Malattie Dell'Apparato RespiratorioAffect (psychology)Human lungMedication AdherenceOlder patientsPartial lossInternal MedicinemedicineHumansAnti-Asthmatic AgentsIntensive care medicineAsthmaAgedCOPDbusiness.industryAsthma treatmentAge Factorsmedicine.diseaseComorbidityLung functionAsthmarespiratory tract diseasesClinical Practicemedicine.anatomical_structurePhysical therapybusinessAirway inflammationEuropean journal of internal medicine
researchProduct

Can the effects of gender, menopause and ageing on lipid levels be differentiated?

2016

The menopause, as well as ageing in both genders, can influence cardiovascular disease (CVD) risk1. An atherogenic lipoprotein profile, including small dense low density lipoprotein (sdLDL) particles, can be present even in normolipidaemic healthy young individuals (about 6%)2. If confirmed by larger studies, it will be necessary to consider different risk stratifications for those with atherogenic normolipidaemia and those with non-atherogenic hypercholesterolaemia. Furthermore, other changes associated with the menopause (increase in lipoprotein (a) [Lp(a)] levels, central obesity, endothelial dysfunction and systemic inflammation) may contribute to pro-atherogenic changes, while ethnicit…

Agingmedicine.medical_specialtyEndocrinology Diabetes and MetabolismDisease030204 cardiovascular system & hematologySystemic inflammation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyInternal medicinemedicineHumans030212 general & internal medicineEndothelial dysfunctionbusiness.industrymedicine.diseaseLipidsObesityMenopauseEndocrinologychemistryAgeingLow-density lipoproteinFemaleMenopausemedicine.symptombusinessLipoproteinClinical Endocrinology
researchProduct

The value of neutrophil and lymphocyte count in frail older women.

2013

Increasing evidence suggests that systemic inflammation is associated with many pathophysiological processes including frailty in older adults. We evaluated the relationships between white blood cell subtypes, geriatric assessment, and frailty syndrome and in particular, how they correlate with individual frailty criteria (involuntary loss of weight, low energy or exhaustion, slow mobility, muscle weakness, and low physical activity) in frail older women. There was a significant and positive correlation between the frailty score and neutrophil count, but a significantly negative correlation was found when this score was compared to the lymphocyte count. These associations were significant o…

Agingmedicine.medical_specialtyNeutrophilsLymphocyteFrail ElderlyFrailty syndromePilot ProjectsSystemic inflammationPhysical strengthBiochemistryLeukocyte CountEndocrinologyWeight lossWhite blood cellInternal medicineWeight LossGeneticsmedicineHumansLymphocyte CountLymphocytesMuscle StrengthMolecular BiologyExerciseGeriatric AssessmentAged 80 and overHand Strengthbusiness.industryMuscle weaknessCell Biologymedicine.diseasemedicine.anatomical_structureCross-Sectional StudiesImmune System DiseasesPhysical FitnessPhysical therapyAbsolute neutrophil countFemalemedicine.symptombusinessExperimental gerontology
researchProduct

Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid de…

2012

Alzheimer's disease (AD) is characterized by amyloid-beta deposition in amyloid plaques, neurofibrillary tangles, inflammation, neuronal loss, and cognitive deficits. Cannabinoids display neuromodulatory and neuroprotective effects and affect memory acquisition. Here, we studied the impact of cannabinoid receptor type 1 (CB1) deficiency on the development of AD pathology by breeding amyloid precursor protein (APP) Swedish mutant mice (APP23), an AD animal model, with CB1-deficient mice. In addition to the lower body weight of APP23/CB1(-/-) mice, most of these mice died at an age before typical AD-associated changes become apparent. The surviving mice showed a reduced amount of APP and its …

Agingmedicine.medical_specialtyPathologyCannabinoid receptormedicine.medical_treatmentMutantMice TransgenicInflammationDiseaseNeuroprotectionAmyloid beta-Protein PrecursorMiceReceptor Cannabinoid CB1Alzheimer DiseaseCell Line TumorInternal medicinemental disordersmedicineAmyloid precursor proteinAnimalsHumansMaze LearningCognitive impairmentAmyloid beta-Peptidesbiologybusiness.industryGeneral NeuroscienceBody WeightAge FactorsBrainPeptide FragmentsDisease Models AnimalEndocrinologyGene Expression RegulationMutationbiology.proteinlipids (amino acids peptides and proteins)MicrogliaNeurology (clinical)CannabinoidGeriatrics and Gerontologymedicine.symptomCognition DisordersbusinessDevelopmental BiologyNeurobiology of Aging
researchProduct

Magnesium and type 2 diabetes.

2015

Type 2 diabetes is frequently associated with both extracellular and intracellular magnesium (Mg) deficits. A chronic latent Mg deficit or an overt clinical hypomagnesemia is common in patients with type 2 diabetes, especially in those with poorly controlled glycemic profiles. Insulin and glucose are important regulators of Mg metabolism. Intracellular Mg plays a key role in regulating insulin action, insulin-mediated-glucose-uptake and vascular tone. Reduced intracellular Mg concentrations result in a defective tyrosine-kinase activity, postreceptorial impairment in insulin action and worsening of insulin resistance in diabetic patients. A low Mg intake and an increased Mg urinary loss app…

Agingmedicine.medical_specialtySettore MED/09 - Medicina InternaDiabetes riskEndocrinology Diabetes and Metabolismmedicine.medical_treatmentType 2 diabetesHypomagnesemiaInsulin resistanceInternal medicineDiabetes mellitusInternal MedicinemedicineMagnesiumEndotheliumAging; Endothelium; Hypertension; Inflammation; Insulin resistance; Magnesium; Metabolic syndrome; Type 2 diabetesGlycemicInflammationbusiness.industryInsulinInsulin resistanceType 2 diabetesMinireviewsmedicine.diseaseMetabolic syndromeEndocrinologyHypertensionMetabolic syndromebusinessWorld journal of diabetes
researchProduct

Anthropometric Variables as Mediators of the Association of Changes in Diet and Physical Activity With Inflammatory Profile

2020

AbstractBackgroundMechanisms underlying the associations of high levels of physical activity (PA) and adherence to the Mediterranean diet (MedDiet) with a better inflammatory profile remain unclear. Our objective was to assess the mediating role of changes in body mass index (BMI) and waist circumference (WC), as markers of body fat in the association of changes in PA and adherence to the MedDiet, with changes in the inflammatory profile.MethodThis study included 489 adults, aged 55–75 years, from the PREDIMED-Plus multicenter lifestyle intervention trial. An inflammatory score was calculated, based on 8 blood biomarkers: high-sensitivity C-reactive protein, interleukin 6, interleukin 8, in…

Agingmedicine.medical_specialtyWaistMediterranean diet030204 cardiovascular system & hematologyDiet Mediterraneanlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawMediterranean dietInternal medicinemedicineHumans030212 general & internal medicineskin and connective tissue diseasesExerciseLife StyleBody mass indexInflammation2. Zero hungerbiologybusiness.industryLeptinC-reactive proteinAnthropometrybiology.proteinMediation analysisWaist circumferenceInterleukin 18sense organsGeriatrics and GerontologybusinessBody mass indexBiomarkersThe Journals of Gerontology: Series A
researchProduct

Inflammation, genes and zinc in ageing and age-related diseases.

2006

Lifelong antigenic burden determines a condition of chronic inflammation, with increased lymphocyte activation and pro-inflammatory cytokine production. A large number of studies have documented changes in Zn metabolism in experimental animal models of acute and chronic inflammation and in human chronic inflammatory diseases. In particular, modification of zinc plasma concentration as well as intracellular disturbance of antioxidant intracellular pathways have been found associated to age-related inflammatory diseases, like atherosclerosis. Zinc deficiency is extremely diffused in aged people that are educated to avoid meat and other high Zn-content foods due to fear of cholesterol. Rather,…

Agingmedicine.medical_treatmentLongevityGene ExpressionInflammationBiologychemistry.chemical_compoundmedicinecytokine interleukin 6 metallothionein tumor necrosis factor alpha zincAnimalsHumansGeneTranscription factorCellular SenescenceInflammationPolymorphism GeneticCholesterolInterleukin-6Tumor Necrosis Factor-alphamedicine.diseaseAtherosclerosisImmunity InnateZincCytokinechemistryAgeingImmunologyZinc deficiencyCytokinesMetallothioneinGeriatrics and Gerontologymedicine.symptomGerontologyIntracellular
researchProduct

Exploring New Kingdoms: The Role of Extracellular Vesicles in Oxi-Inflamm-Aging Related to Cardiorenal Syndrome

2021

The incidence of age associated chronic diseases has increased in recent years. Although several diverse causes produce these phenomena, abundant evidence shows that oxidative stress plays a central role. In recent years, numerous studies have focused on elucidating the role of oxidative stress in the development and progression of both aging and chronic diseases, opening the door to the discovery of new underlying mechanisms and signaling pathways. Among them, senolytics and senomorphics, and extracellular vesicles offer new therapeutic strategies to slow the development of aging and its associated chronic diseases by decreasing oxidative stress. In this review, we aim to discuss the role …

AgingsenescenceMedicinaPhysiologyClinical Biochemistryoxi-inflamm-agingRM1-950ReviewSenescenceBiochemistryage-related pathologiesoxidative stressMolecular BiologyInflammationSenolyticsOxi-inflamm-agingagingCell BiologyExtracellular vesiclesOxidative stressinflammationsenolyticsMedicineTherapeutics. PharmacologyAge-related pathologiesextracellular vesiclesAntioxidants
researchProduct